Battery electrode binder material

US12388089B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12388089-B2
Application numberUS-202318462577-A
CountryUS
Kind codeB2
Filing dateSep 7, 2023
Priority dateSep 28, 2022
Publication dateAug 12, 2025
Grant dateAug 12, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods of preparing a dry powder blend co-coagulating conductive carbon black particles and fibrillizable polytetrafluoroethylene particles from an aqueous dispersion and drying the co-coagulate are described. Dry powders prepared by such methods and electrodes prepared from such powders are also described.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of preparing a powder comprising forming a mixture by combining conductive carbon black particles having a D50 particle size of 10 to 150 nanometers with an aqueous latex comprising fibrillizable polytetrafluoroethylene particles having a D50 particle size of 40 to 200 nanometers, wherein a size ratio of the D50 particle size of the fibrillizable polytetrafluoroethylene particles to the D50 particle size of the carbon black particles is from 1.1:1 to 5:1, inclusive; co-coagulating the conductive carbon black particles and the fibrillizable polytetrafluoroethylene particles to form a co-coagulate; and drying the co-coagulate to form a powder blend comprising at least 90 wt. % of the conductive carbon black particles and the fibrillizable polytetrafluoroethylene particles, based on the total weight of the powder blend, wherein the powder blend comprises 15 to 45 wt. % of the conductive carbon black particles and 55 to 85 wt. % of the fibrillizable polytetrafluoroethylene particles. 2. The method of claim 1 , further comprising homogenizing the mixture prior to co-coagulating the conductive carbon black particles and the fibrillizable polytetrafluoroethylene particles. 3. The method of claim 1 , wherein a ratio of weight of the fibrillizable polytetrafluoroethylene particles to weight of the conductive carbon black particles in the powder is from 2:1 to 4:1. 4. The method of claim 3 , wherein the aqueous latex has a pH of 4 to 6 and a surface tension of 15 to 30 mN/m. 5. The method of claim 1 , wherein the conductive carbon black particles have a D50 particle size of 20 to 60 nanometers. 6. The method of claim 5 , wherein the fibrillizable polytetrafluoroethylene particles have a D50 particle size of 60 to 90 nanometers. 7. The method of claim 1 , wherein the mixture is formed by combining an aqueous dispersion of the conductive carbon black particles with the aqueous latex comprising the fibrillizable polytetrafluoroethylene particles. 8. A powder made the method of claim 1 . 9. A powder comprising at least 90 wt. % of a co-coagulated blend of conductive carbon black particles having a D50 particle size of 10 to 150 nanometers and fibrillizable polytetrafluoroethylene particles having a D50 particle size of 40 to 200 nanometers, wherein a ratio of weight of the fibrillizable polytetrafluoroethylene particles to weight of the conductive carbon black particles in the powder is from 1.1:1 to 5:1, inclusive. 10. The powder of claim 9 , comprising 20 to 40 wt. % of the conductive carbon black particles and 60 to 80 wt. % of the fibrillizable polytetrafluoroethylene particles. 11. The powder of claim 9 , wherein the conductive carbon black particles have a D50 particle size of 20 to 60 nanometers and the fibrillizable polytetrafluoroethylene particles have a D50 particle size of 60 to 90 nanometers. 12. The powder of claim 9 , wherein a size ratio of the D50 particle size of the fibrillizable polytetrafluoroethylene particles to the D50 particle size of the carbon black particles is from 2:1 to 4:1, inclusive. 13. A powder of claim 9 further comprising a thermally conductive filler, optionally wherein the thermally conductive filler is selected from the group consisting of boron nitride, aluminum oxide, and combinations thereof. 14. A method of preparing an electrode comprising spreading the powder of claim 9 on a support and fibrillating the fibrillizable polytetrafluoroethylene particles. 15. An electrode prepared by the method of claim 14 .

Assignees

Inventors

Classifications

  • H01M4/623Primary

    fluorinated polymers · CPC title

  • H01M4/625Primary

    Carbon or graphite · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12388089B2 cover?
Methods of preparing a dry powder blend co-coagulating conductive carbon black particles and fibrillizable polytetrafluoroethylene particles from an aqueous dispersion and drying the co-coagulate are described. Dry powders prepared by such methods and electrodes prepared from such powders are also described.
Who is the assignee on this patent?
3M Innovative Properties Company
What technology area does this patent fall under?
Primary CPC classification H01M4/623. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).